![Neil Khoury, MD Profile](https://pbs.twimg.com/profile_images/1811941469323718656/5l_WLYVH_x96.jpg)
Neil Khoury, MD
@NeilKhouryMD
Followers
897
Following
247
Statuses
123
Chief GI Fellow @UConnGI | Internal medicine trained at NewYork-Presbyterian Brooklyn Methodist - views are my own
Joined September 2023
Proposed algorithm for Resmetirom use for MASLD w/ F2-3 fibrosis, courtesy of @AmJGastro 💊Prescribing considerations: - 80mg qd dosing - ⬆️ to 100mg if wt 100kg+ - ⬇️ to 60mg if pt on Plavix - Avoid if pt on Gemfibrozil - Limit concurrent statin dosing (atorva 40, rosuva 20)
0
43
105
RT @AmerGastroAssn: 📢 New guideline: Learn how to prevent and manage hepatitis B reactivation in patients on immunosuppressive drugs. Read…
0
33
0
RT @UConnGI: We had an excellent GI Grand Rounds lecture on “Sex Differences in Digestive Diseases: Endometriosis and Its Gut Connection” 💩…
0
3
0
RT @ebtapper: Read this A review of reported adverse events for medications to treat alcohol use disorder From @doc_sooyoung we must…
0
15
0
@KMonkemuller This appears to be the second portion of the duo so the orientation should be slightly different than the bulb orientation that we are familiar with for describing duo bulb ulcers (since the second portion dips downwards). Perhaps @AmerGastroAssn can weigh in 🙂
1
0
2
FDA Approves First Medication for Obstructive Sleep Apnea Tirzepatide, a GLP-1 agonist, is now FDA approved for moderate to severe OSA in adults with obesity. Based on data from 2 RCTs that showed improved AHI from baseline. Good to know for #MASLD pts
1
2
12
RT @AmerGastroAssn: Get practical tips for implementing AI 🤖 in clinical workflows and understand its use as a research tool and emerging e…
0
4
0
RT @JHashashMD: 🔥🔊@AmerGastroAssn Clinical Practice Update on Healthcare Maintenance in #IBD
@AGA_CGH @dr_fcalderaibd @SunandaKaneMD and @…
0
59
0
RT @NFL: Proud to stand with the @BuffaloBills, @HamlinIsland and @American_Heart in support of the HEARTS Act, which will provide lifesavi…
0
154
0
Several promising blood-based biomarkers/panels are in various phases of validation. GALAD is furthest along. Shows promise for 📈 sensitivity for early stage HCC detection and likely increased adherence to surveillance! Potential to reduce mortality in HCC 🙏 @AmJGastro
1
12
26
Ultrasound has low sensitivity for early HCC detection alone & 63% w/ AFP HCC 5-year survival is >70% for early-stage HCC vs. <10% for advanced stages. Can blood-based biomarkers (other than AFP) help w/ early detection? 🤔 @AmJGastro #LiverTwitter
1
4
33
RT @UConnGI: Proud of our PGY4 GI Fellow Karthik for being highlighted in the GME Fall Newsletter 👏 #FellowSpotlight #GITwitter
https://t.…
0
2
0